Cholinesterase inhibitors: A new class of psychotropic compounds.
about
Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognitionWhat's in a name? The evolution of the nomenclature of antipsychotic drugsCurrent pharmacologic options for patients with Alzheimer's diseaseRational choice of cholinesterase inhibitor for the treatment of Alzheimer's disease in Canada: a comparative economic analysisSerum anticholinergic activity: a possible peripheral marker of the anticholinergic burden in the central nervous system in Alzheimer's diseasePathophysiological effects of synthetic derivatives of polymeric alkylpyridinium salts from the marine sponge, Reniera saraiNeural Correlates for Apathy: Frontal-Prefrontal and Parietal Cortical- Subcortical CircuitsMini Review: Anticholinergic Activity as a Behavioral Pathology of Lewy Body Disease and Proposal of the Concept of "Anticholinergic Spectrum Disorders"Stroke, dementia, and drug deliveryCholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literatureNew computer-aided diagnosis of dementia using positron emission tomography: brain regional sensitivity-mapping methodRecommendations for the management of behavioral and psychological symptoms of dementia.Acetylcholine receptor and behavioral deficits in mice lacking apolipoprotein ESuccessful use of donepezil for the treatment of dementia with Lewy bodies.Traumatic brain injury in older adults.Relationship of exercise and other risk factors to depression of Alzheimer's disease: the LASER-AD study.Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a case report.Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a review of the literatureEffect of rivastigmine on mobility of patients with higher-level gait disorder: a pilot exploratory study.Apathy in neurologic disorders.Pharmacotherapy of behavioral and psychological symptoms of dementia: time for a different paradigm?The transport of choline.Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease.Cholinesterase inhibitors for behavioral disturbance in dementia.Efficacy and Tolerability of a Combination Treatment of Memantine and Donepezil for Alzheimer's Disease: A Literature Review Evidence.A 12-week open-label pilot study of donepezil for cognitive functioning and instrumental activities of daily living in late-life bipolar disorder.Bipolar affective disorder, type II, apparently precipitated by donepezil.The role of acetylcholine in cocaine addiction.[Therapy of cognitive deficits in schizophrenia with acetylcholinesterase inhibitors. A systematic overview]Pharmacologic therapy of dementia with Lewy bodies.Neuropsychiatric aspects of Parkinson's disease: recent advances.Frequency of behavioral symptoms characterizes agitation in Alzheimer's disease.Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: a factor analytic approach.Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer's disease.Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease.Apathy in Parkinson's disease.Clinical pharmacology of anti-Alzheimer drugs.Acetylcholinesterase inhibition ameliorates deficits in motivational driveIs psychosis a neurobiological syndrome?Treatment of Visual Hallucinations in Schizophrenia by Acetylcholinesterase Inhibitors: a case report
P2860
Q24614080-986F79BB-061E-45C1-8A42-40ADDB49057AQ24671924-4CC3649F-63C6-4A93-BA00-2CF79841F038Q24800530-EDA8DF5B-4A76-4BD9-BCD8-9FCF3A8EE5F5Q24805169-D0A39465-B473-429F-B0CA-0924752B839DQ27009120-96CE20F5-D7AC-4553-A691-15637C2E6ABDQ27012958-8C55EB0D-827E-4B7E-9A11-97D1FD4C2207Q28069542-24BBF7AF-56B2-44D4-8ADF-686B6B28F312Q28070151-5223FD00-F837-466C-B31A-C88A17A99E3BQ28166505-9DB2FE72-86CB-421E-AC25-BA554BB1ACD8Q28276669-531378FB-C098-4036-B25C-FB0BF0DFE001Q28744562-62D0636F-09D9-488B-AAD4-B545F5DD70C7Q30327961-37FF872B-6AF4-48A1-B964-84EAE4DE1E0EQ30471824-838FC22C-7D90-4E23-903B-45B601AE9DEDQ32052939-EEC912B7-09BB-407B-BAE7-B399D268F3EEQ33184379-455E34F1-83E6-4B9B-8D95-8469B31776D1Q33212018-5FBF9BB6-6D57-462B-8AFA-84171CB296D5Q33686420-52D12853-65AA-4166-98F6-939FAE2E32F6Q33686426-8506A370-CEB1-49E6-82BB-73D121F52394Q33804754-9D9C189C-D003-4986-BA95-BE8293AF0C0BQ34108538-22E4D043-7510-407A-9760-CFF410DEDDE0Q34146983-AC67E9C1-CB05-424E-8027-0F446BC6BE69Q34149885-E377A74B-E170-4B21-969F-158009016301Q34233759-950A6BAD-C1C1-416F-B1F3-C5ADD0256247Q34251448-E9ED8624-3F4F-454E-83EC-D0EAD9E88B2BQ34301111-FFB313BF-2575-4C29-B3FE-6EDA80E13F65Q34586671-2F44EA53-0F44-474F-BCAB-88B74487AB18Q34625266-E277CF09-7E85-41D8-99A1-B8A1123447A2Q34700186-E9032516-2BF1-4703-B3E6-BFC1B98ED080Q34706665-BA9C5BC9-A479-448F-A450-61E58FDC0D31Q35029479-6082E446-DBE1-4E1A-A02A-43444DD7B203Q35103472-6480A71A-9F6A-4736-8CD1-B89E6848E585Q35215617-DFC26CAC-88EE-44BC-98CE-367156CF35A5Q35226430-AEE7B188-F294-4A6D-BEE0-613B5B772031Q35469584-CCE34B81-083F-4B00-A4DA-FEE15CCF039EQ35486482-0668644D-D843-4313-B6F8-3E163F7C1C52Q35560120-6184CDD2-A03E-43F1-96CE-5AE7C23F7DDDQ35688610-D5B4592B-3A4F-438D-8A6E-0F274AF13DA7Q35893873-1C514805-766E-4D0B-BF73-580C703417A8Q36000687-A90752A2-5899-4F92-B34C-3BB76671F36EQ36092585-8C3571D0-7563-48F1-BFCC-24DA80818DD8
P2860
Cholinesterase inhibitors: A new class of psychotropic compounds.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cholinesterase inhibitors: A new class of psychotropic compounds.
@ast
Cholinesterase inhibitors: A new class of psychotropic compounds.
@en
type
label
Cholinesterase inhibitors: A new class of psychotropic compounds.
@ast
Cholinesterase inhibitors: A new class of psychotropic compounds.
@en
prefLabel
Cholinesterase inhibitors: A new class of psychotropic compounds.
@ast
Cholinesterase inhibitors: A new class of psychotropic compounds.
@en
P356
P1476
Cholinesterase inhibitors: A new class of psychotropic compounds.
@en
P2093
Cummings JL
P356
10.1176/AJP.157.1.4
P407
P577
2000-01-01T00:00:00Z